This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen).

The global Ethinyl estradiol and levonorgestrel market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ethinyl estradiol and levonorgestrel volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ethinyl estradiol and levonorgestrel market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ethinyl estradiol and levonorgestrel in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ethinyl estradiol and levonorgestrel manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Teva
Pfizer
Aurobindo Pharma
Laboratorios Leon Farma
Glenmark
Allergan
Avion Pharmaceuticals
LUPIN
Mayne Pharma
Novast
Mylan
Amneal Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
0.02mg/0.1mg
0.03mg/0.15mg
0.01mg/0.15mg
0.02mg/0.09mg

Segment by Application
Hospital
Drug store